PUK1 REACHING TARGET HEMATOCRITS WITH EPOETIN- IS THE INFERENCE OF A SURVIVAL BENEFIT VALID?
Abstract
Authors
Y Zhang M Thamer K Stefanik D Scharfstein J Kaufman
Y Zhang M Thamer K Stefanik D Scharfstein J Kaufman
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now